Tuesday, June 6, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Featured News

Medical Countermeasure Nonclinical Studies Network Contract Awards

by Global Biodefense Staff
March 30, 2017
Sequencing Medical Research

The Nonclinical Studies Network is a key element in the successful development of U.S. medical countermeasures for biological threats, particularly since efficacy of products directed against most of these threats cannot be verified using clinical studies.

The U.S. government this month awarded multiple Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts to support this network of GLP laboratories to provide capabilities for nonclinical animal studies, analytical services, and toxicology services.

The following organizations were selected:

  • Battelle Memorial Institute
  • IIT Research Institute
  • Lovelace Biomedical & Environmental Research Institute
  • MRI Global
  • Public Health England
  • Southern Research Institute
  • SRI International

The effort is on behalf of the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness & Response (ASPR).

BARDA anticipates that contracts awarded from under this ID/IQ will serve to facilitate the animal model development of medical countermeasures and supportive reagents and assays for regulatory acceptance in the U.S.

Source: Solicitation Number: RFP-16-100-SOL-00008

Tags: Animal ModelsAntitoxinsAntiviralsASPRAwardsBARDABattelleHHSVaccines

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics
Industry News

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023
Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC